$PETS
PETMED EXPRESS INC

2023 Q3 Form 10-Q Financial Statement

#000104013023000052 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $71.00M $78.24M $62.41M
YoY Change 8.57% 11.48% -5.45%
Cost Of Revenue $50.94M $55.72M $45.03M
YoY Change 8.51% 10.89% -3.39%
Gross Profit $20.06M $22.53M $17.38M
YoY Change 8.73% 12.95% -10.39%
Gross Profit Margin 28.26% 28.79% 27.85%
Selling, General & Admin $18.79M $22.98M $23.50M
YoY Change 28.42% 46.34% 101.66%
% of Gross Profit 93.66% 102.0% 135.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.713M $1.678M $994.0K
YoY Change 99.65% 122.84% 44.69%
% of Gross Profit 8.54% 7.45% 5.72%
Operating Expenses $20.50M $24.65M $24.49M
YoY Change 32.36% 49.85% 98.49%
Operating Profit -$441.0K -$2.128M -$7.112M
YoY Change -114.89% -160.97% -200.78%
Interest Expense $570.0K $620.0K $857.0K
YoY Change 46.91% 429.91% 831.52%
% of Operating Profit
Other Income/Expense, Net $824.0K $506.0K $226.0K
YoY Change 26.96% 60.63% -20.7%
Pretax Income $383.0K -$1.002M -$6.029M
YoY Change -89.39% -126.33% -181.1%
Income Tax $500.0K -$115.0K -$927.0K
% Of Pretax Income 130.55%
Net Earnings -$70.00K -$887.0K -$5.102M
YoY Change -102.71% -131.96% -184.11%
Net Earnings / Revenue -0.1% -1.13% -8.18%
Basic Earnings Per Share $0.00 -$0.04
Diluted Earnings Per Share $0.00 -$0.04 -$0.25
COMMON SHARES
Basic Shares Outstanding 21.17M shares 21.17M shares 21.08M shares
Diluted Shares Outstanding 20.38M shares 20.33M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.50M $61.53M $104.1M
YoY Change -44.59% -41.63% -6.3%
Cash & Equivalents $53.50M $61.53M $104.1M
Short-Term Investments
Other Short-Term Assets $11.10M $10.08M $6.602M
YoY Change 83.23% 128.27% 19.02%
Inventory $18.90M $32.32M $19.02M
Prepaid Expenses
Receivables $2.174M $1.894M $1.740M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $85.66M $105.8M $131.5M
YoY Change -38.02% -21.13% -12.94%
LONG-TERM ASSETS
Property, Plant & Equipment $26.97M $29.23M $26.18M
YoY Change 7.06% 18.38% 7.01%
Goodwill $22.45M $20.74M $0.00
YoY Change
Intangibles $12.18M $12.67M $5.860M
YoY Change 1373.37% 581.4%
Long-Term Investments $5.000M
YoY Change
Other Assets $5.200M $7.270M $628.0K
YoY Change 45.4%
Total Long-Term Assets $73.61M $74.91M $32.67M
YoY Change 137.08% 145.17% 28.99%
TOTAL ASSETS
Total Short-Term Assets $85.66M $105.8M $131.5M
Total Long-Term Assets $73.61M $74.91M $32.67M
Total Assets $159.3M $180.7M $164.1M
YoY Change -5.9% 9.71% -6.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.38M $40.04M $25.21M
YoY Change 5.83% 135.08% -8.33%
Accrued Expenses $11.70M $14.04M $11.29M
YoY Change 77.68% 132.94% 98.16%
Deferred Revenue $3.600M $3.200M $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $40.70M $57.32M $36.50M
YoY Change 33.14% 139.87% 9.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.825M $5.093M $3.825M
YoY Change
Total Long-Term Liabilities $3.825M $5.093M $3.825M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $40.70M $57.32M $36.50M
Total Long-Term Liabilities $3.825M $5.093M $3.825M
Total Liabilities $45.60M $62.42M $40.32M
YoY Change 46.57% 154.35% 18.13%
SHAREHOLDERS EQUITY
Retained Earnings $91.88M $98.26M $105.5M
YoY Change -25.45% -22.62% -19.16%
Common Stock $21.00K $21.00K $21.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $113.7M $118.3M $123.8M
YoY Change
Total Liabilities & Shareholders Equity $159.3M $180.7M $164.1M
YoY Change -5.9% 9.71% -6.92%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$70.00K -$887.0K -$5.102M
YoY Change -102.71% -131.96% -184.11%
Depreciation, Depletion And Amortization $1.713M $1.678M $994.0K
YoY Change 99.65% 122.84% 44.69%
Cash From Operating Activities -$780.0K $562.0K $9.724M
YoY Change -38.68% -91.19% 11.55%
INVESTING ACTIVITIES
Capital Expenditures $990.0K $1.153M $1.931M
YoY Change -173.12% 17.41% -497.33%
Acquisitions $35.86M
YoY Change
Other Investing Activities $0.00 -$35.86M $0.00
YoY Change 617.18%
Cash From Investing Activities -$990.0K -$37.01M -$1.931M
YoY Change -26.88% 518.72% 297.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.300M -6.102M -6.135M
YoY Change 0.93% 0.63% 1.2%
NET CHANGE
Cash From Operating Activities -780.0K 562.0K 9.724M
Cash From Investing Activities -990.0K -37.01M -1.931M
Cash From Financing Activities -6.300M -6.102M -6.135M
Net Change In Cash -8.070M -42.55M 1.658M
YoY Change -9.0% 651.01% -23.56%
FREE CASH FLOW
Cash From Operating Activities -$780.0K $562.0K $9.724M
Capital Expenditures $990.0K $1.153M $1.931M
Free Cash Flow -$1.770M -$591.0K $7.793M
YoY Change -2258.54% -110.95% -15.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15711000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9351000 usd
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
7265000 usd
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
6349000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1678000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
753000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
24654000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
16453000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2128000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3490000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
620000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
117000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
506000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
198000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1126000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
315000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1002000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3805000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-115000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1030000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-887000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2775000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20333000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20208000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20333000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20291000 shares
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-887000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2775000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
1678000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
753000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1760000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1536000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-450000 usd
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-294000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
19000 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
45000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
46000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-86000 usd
CY2023Q2 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
10185000 usd
CY2022Q2 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-9880000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-335000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-681000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2390000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-451000 usd
CY2023Q2 pets Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-196000 usd
CY2022Q2 pets Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9115000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10469000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1369000 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
97000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-205000 usd
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
253000 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
839000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
562000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6380000 usd
CY2023Q2 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
0 usd
CY2022Q2 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
5000000 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
35859000 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1153000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
982000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37012000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5982000 usd
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6102000 usd
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
6064000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6102000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6064000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42552000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5666000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104086000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111080000 usd
CY2023Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1507000 usd
CY2022Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
791000 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200000 usd
CY2023Q2 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200000 usd
CY2023Q2 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
70187000 usd
CY2022Q2 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2023Q2 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
8057000 usd
CY2023Q2 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.115
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-887000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2775000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20333000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20208000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
73000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20333000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20291000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61500000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104100000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13160000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
489000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12671000 usd
CY2023Q2 pets Intangible And Other Assets Gross
IntangibleAndOtherAssetsGross
18160000 usd
CY2023Q2 pets Intangibles And Other Assets Accumulated Amortization
IntangiblesAndOtherAssetsAccumulatedAmortization
489000 usd
CY2023Q2 pets Intangible And Other Assets
IntangibleAndOtherAssets
17671000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 usd
CY2023Q1 pets Intangible And Other Assets Gross
IntangibleAndOtherAssetsGross
5860000 usd
CY2023Q1 pets Intangibles And Other Assets Accumulated Amortization
IntangiblesAndOtherAssetsAccumulatedAmortization
0 usd
CY2023Q1 pets Intangible And Other Assets
IntangibleAndOtherAssets
5860000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.066
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
215000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
14000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
229000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
209000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2220000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
623000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
501000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
488000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
502000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
42000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2156000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
126000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2030000 usd
CY2023 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
7800000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.115
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001040130-23-000052-index-headers.html Edgar Link pending
0001040130-23-000052-index.html Edgar Link pending
0001040130-23-000052.txt Edgar Link pending
0001040130-23-000052-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20230630.htm Edgar Link pending
pets-20230630.xsd Edgar Link pending
pets-20230630xexx311.htm Edgar Link pending
pets-20230630xexx312.htm Edgar Link pending
pets-20230630xexx321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pets-20230630_def.xml Edgar Link unprocessable
pets-20230630_lab.xml Edgar Link unprocessable
pets-20230630_pre.xml Edgar Link unprocessable
pets-20230630_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pets-20230630_cal.xml Edgar Link unprocessable